Emerging role of linker histone variant H1x as a biomarker with prognostic value in astrocytic gliomas. A multivariate analysis including trimethylation of H3K9 and H4K20.

MLA

Sepsa, Athanasia, et al. “Emerging Role of Linker Histone Variant H1x as a Biomarker with Prognostic Value in Astrocytic Gliomas. A Multivariate Analysis Including Trimethylation of H3K9 and H4K20.” PloS One, vol. 10, no. 1, Jan. 2015, p. e0115101. EBSCOhost, https://doi.org/10.1371/journal.pone.0115101.

APA

Sepsa, A., Levidou, G., Gargalionis, A., Adamopoulos, C., Spyropoulou, A., Dalagiorgou, G., Thymara, I., Boviatsis, E., Themistocleous, M. S., Petraki, K., Vrettakos, G., Samaras, V., Zisakis, A., Patsouris, E., Piperi, C., & Korkolopoulou, P. (2015). Emerging role of linker histone variant H1x as a biomarker with prognostic value in astrocytic gliomas. A multivariate analysis including trimethylation of H3K9 and H4K20. PloS One, 10(1), e0115101. https://doi.org/10.1371/journal.pone.0115101

Chicago

Sepsa, Athanasia, Georgia Levidou, Antonis Gargalionis, Christos Adamopoulos, Anastasia Spyropoulou, Georgia Dalagiorgou, Irene Thymara, et al. 2015. “Emerging Role of Linker Histone Variant H1x as a Biomarker with Prognostic Value in Astrocytic Gliomas. A Multivariate Analysis Including Trimethylation of H3K9 and H4K20.” PloS One 10 (1): e0115101. doi:10.1371/journal.pone.0115101.